triazoles has been researched along with Biliary Tract Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akara-Amornthum, P; Choksi, S; Jitkaew, S; Lomphithak, T; Tohtong, R | 1 |
| Alinger, B; Berr, F; Di Fazio, P; Fuereder, J; Kiesslich, T; Neureiter, D; Oberdanner, C; Ocker, M; Pichler, M; Wachter, J | 1 |
2 other study(ies) available for triazoles and Biliary Tract Cancer
| Article | Year |
|---|---|
Key necroptotic proteins are required for Smac mimetic-mediated sensitization of cholangiocarcinoma cells to TNF-α and chemotherapeutic gemcitabine-induced necroptosis.
Topics: Biliary Tract Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Caspase Inhibitors; Cell Cycle Checkpoints; Cell Line, Tumor; Cholangiocarcinoma; Deoxycytidine; Drug Synergism; Gemcitabine; Humans; Necroptosis; Protein Kinases; Receptor-Interacting Protein Serine-Threonine Kinases; RNA Interference; RNA, Small Interfering; Triazoles; Tumor Necrosis Factor-alpha | 2020 |
Influence of five potential anticancer drugs on wnt pathway and cell survival in human biliary tract cancer cells.
Topics: Antineoplastic Agents; Benzimidazoles; beta Catenin; Biliary Tract Neoplasms; Cadherins; Cell Line, Tumor; Cell Survival; Clinical Trials as Topic; Cyclin D1; Flavonoids; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Ki-67 Antigen; Proliferating Cell Nuclear Antigen; Quercetin; RNA, Messenger; Sulfonamides; Triazoles; Vimentin; Wnt Signaling Pathway | 2012 |